Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce the completion of the Qualifying Transaction, closing the $6 million subscription receipt financing.
Universal Ibogaine and PSQ are pleased to announce that PSQ has SEDAR filed...
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ" or the "Company") a capital pool company, and Universal Ibogaine Inc. ("UI") are pleased to announce that PSQ has received conditional approval from the TSX Venture Exchange ("TSXV") for its previously announced Qualifying Transaction (the "Transaction", as defined under TSX.V Policy 2.4) with UI. Pursuant to the Transaction, PSQ will [...]
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ" or the "Company") a capital pool company, is pleased to provide the following announcements and updates: Concurrent Financing In connection with the non-brokered private placement of subscription receipts ("Subscription Receipts") to be undertaken by 1266855 B.C. Ltd. ("Subco"), a wholly owned subsidiary of PSQ, of up to 24,000,000 Subscription Receipts [...]
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ") a capital pool company, and Universal Ibogaine Inc. ("UI") are pleased to announce that they have jointly engaged Boustead Securities, LLC (“Boustead”), a US investment banking firm, to participate in the closing of their current $6 million go-public financing raise (the “Offering”). The Offering is part of PSQ’s previously announced [...]
Calgary, Alberta - P Squared Renewables Inc. (TSXV: PSQ.P) ("PSQ") a capital pool company, is pleased to announce that it has engaged a Canadian investment banking firm to act as sponsor for its previously announced proposed Qualifying Transaction (the "QT") with Universal Ibogaine Inc. ("UI"). The potential sponsor firm is currently in process of undertaking due diligence review procedures, following [...]
HEALTH. BUSINESS. LEGALIZATION. THE TIME HAS COME The August 2020 landmark decision by Health Canada allowing four terminally ill patients to use psilocybin signals a shift in the perception of psychedelics as a legitimate medical and therapeutic solution. Combined with a growing interest in the space among the general public and the emergence of companies engaged in everything from legal [...]
Vancouver, British Columbia - Universal Ibogaine Inc. (“UI” or the “Company”) is pleased to advise that Dr. Rami Batal has been appointed to serve as Chief Executive Officer of Universal Ibogaine effective March 1, 2021. Dr. Batal is a seasoned biopharmaceutical industry executive and a healthcare professional who has a passion for and expertise in mental health, including substance use [...]
© All rights reserved. • Universal Ibogaine Inc.
